ACADIA PHARMACEUTICALS INC — Director's Dealing 2018

Nov 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2018-11-19

Reporting Person: Stankovic Srdjan R. (President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-19	Employee Stock Options (Right to Buy)	$18.12	A	150000	Acquired	2028-11-18	Common Stock (150000)	Direct
2018-11-19	Restricted Stock Units	$	A	25000	Acquired		Common Stock (25000)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vest and become exercisable on November 19, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.

F2: Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.

F3: The restricted stock units vest in four equal annual installments beginning November 19, 2019.